Description
Tukavo 150mg tablet (tucatinib) is a targeted therapy used primarily to treat advanced or metastatic HER2-positive breast cancer.
Additional information
| Brand | Tukavo 150 |
|---|---|
| Generic name | Tucatinib tablets |
| Form | Oral tablets |
| Strength | 150mg |
| Packing | 60 tablets |
| Manufacturer | Zydus |
| Documents | Either PO or prescription |
| Storage | Below 25°C |
Reviews
There are no reviews yet.